Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 6/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 5/20 | 0.43 |
| ▸ | GRIA3 | P42263 | 5/20 | 0.43 |
| ▸ | GRIA4 | P48058 | 5/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5795472 | 1.00 | SLC7A5 (0.46) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL5795469 | 0.88 | SLC7A5 (0.46) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL6239551 | 0.84 | SLC7A5 (0.46) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL6239556 | 0.84 | SLC7A5 (0.46) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL2815963 | 0.81 | GABRR1 (0.57) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL2815970 | 0.81 | GABRR1 (0.57) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| Hydrochloric Acid SCHEMBL25273661 | 0.79 | GABRR1 (0.56) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL5280033 | 0.78 | SLC7A5 (0.49) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL8697806 | 0.78 | SLC7A5 (0.49) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 | |
| SCHEMBL8701267 | 0.78 | SLC7A5 (0.49) | SLC7A5CYP3A4GRIA2GRIA1GRIA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060052287-A1 | Polyethylene glycol - peptide copper complexes and compositions and methods related thereto | PROCYTE CORPORATION (US) | 2006-03-09 | — | — | US | disclosed |
| WO-2006023465-A1 | POLYETHYLENE GLYCOL-PEPTIDE COPPER COMPLEXES AND COMPOSITIONS AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052287-A1 | Polyethylene glycol - peptide copper complexes and compositions and methods related thereto | NGLY1, CUTA, TFRC | SLC7A5 1092/4885CYP3A4 4828/4885GRIA2 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.